These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19937689)

  • 21. Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis.
    Denzer UW; Lüth S
    Best Pract Res Clin Gastroenterol; 2009; 23(3):453-60. PubMed ID: 19505671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
    Pagadala M; Zein CO; McCullough AJ
    Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment by Fibroscan of fibrosis in nonalcoholic fatty liver disease: XL versus M probe?
    Petta S; Craxì A
    Hepatology; 2012 Apr; 55(4):1309; author reply 1309-10. PubMed ID: 22307871
    [No Abstract]   [Full Text] [Related]  

  • 24. Myths and mysteries about staging hepatic fibrosis by fibroscan.
    Vuppalanchi R; Sanyal AJ
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):780-2. PubMed ID: 25451885
    [No Abstract]   [Full Text] [Related]  

  • 25. IS ARFI A USEFUL TOOL FOR NON-INVASIVE EVALUATION OF LIVER STIFFNESS IN NONALCOHOLIC FATTY LIVER DISEASE AND HEPATITIS C?
    Ozturker C; Karagoz E; Sildiroglu HO
    Arq Gastroenterol; 2016; 53(3):212. PubMed ID: 27438430
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hemorrhagic thrombocytemia in association with portal liver cirrhosis].
    Snagovskaia EA; Korostylev VI
    Vrach Delo; 1976 Mar; (3):56-9. PubMed ID: 944970
    [No Abstract]   [Full Text] [Related]  

  • 27. Is past exposure to hepatitis A protective against progressive fibrosis in non-alcoholic fatty liver disease?
    de Silva AP; Kasturiratne A; Liyanage DL; Karunanayaka TK; de S Hewavisenthi SJ; Dassanayake AS; Farrell GC; de Silva HJ
    Liver Int; 2008 Jan; 28(1):147-9. PubMed ID: 18173565
    [No Abstract]   [Full Text] [Related]  

  • 28. Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease.
    Polyzos SA; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):161-7. PubMed ID: 24290839
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatic cirrhosis secondary to nonalcoholic fatty liver disease in a 12-year-old girl with morbid obesity.
    Sharma A; Freese DK; Chandan V; Zarroug AE; Swain JM; Kumar S
    Clin Pediatr (Phila); 2014 Jan; 53(1):86-8. PubMed ID: 23564302
    [No Abstract]   [Full Text] [Related]  

  • 30. Intermittent disconjugate gaze: a novel finding in nonalcoholic steatohepatitis and cryptogenic cirrhosis.
    Al-Osaimi AM; Berg CL; Caldwell SH
    Hepatology; 2005 Apr; 41(4):943. PubMed ID: 15791607
    [No Abstract]   [Full Text] [Related]  

  • 31. Acoustic radiation force-based shear stiffness and non-invasive panels of tests in Japanese patients with nonalcoholic fatty liver disease.
    Yoneda M; Imajo K; Kirikoshi H; Nakajima A
    J Hepatol; 2012 Mar; 56(3):740-1. PubMed ID: 21884671
    [No Abstract]   [Full Text] [Related]  

  • 32. When liver stiffness is not so straight forward and Fibroscan not so simple.
    Lee AU
    J Gastroenterol Hepatol; 2009 Jun; 24(6):934-6. PubMed ID: 19638074
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of acoustic radiation force-based shear stiffness in non-alcoholic fatty liver disease.
    Cross TJ
    J Hepatol; 2012 Apr; 56(4):995; author reply 996. PubMed ID: 21946021
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prospect of liver fibrosis].
    Jia JD
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):5-6. PubMed ID: 19391279
    [No Abstract]   [Full Text] [Related]  

  • 35. Nonlinear distribution of adiponectin in patients with nonalcoholic fatty liver disease limits its use in linear regression analysis.
    Polyzos SA; Kountouras J; Zavos C
    J Clin Gastroenterol; 2010 Mar; 44(3):229-30; author reply 230-1. PubMed ID: 19770674
    [No Abstract]   [Full Text] [Related]  

  • 36. Liver biopsy: the best, not the gold standard.
    Bedossa P; Carrat F
    J Hepatol; 2009 Jan; 50(1):1-3. PubMed ID: 19017551
    [No Abstract]   [Full Text] [Related]  

  • 37. Histopathology of non-alcoholic fatty liver disease.
    Brunt EM
    Clin Liver Dis; 2009 Nov; 13(4):533-44. PubMed ID: 19818303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noninvasive assessment of liver fibrosis: the need for better validation.
    Tsochatzis EA; Germani G; Hall A; Anousou PM; Dhillon AP; Burroughs AK
    Hepatology; 2011 May; 53(5):1781-2; author reply 1782-3. PubMed ID: 21384400
    [No Abstract]   [Full Text] [Related]  

  • 39. 3 Tesla diffusion-weighted MRI for assessing liver fibrosis in nonalcoholic fatty liver disease.
    Papalavrentios L; Sinakos E; Chourmouzi D; Hytiroglou P; Drevelegas K; Drevelegas A; Akriviadis E
    Hepatology; 2013 Jul; 58(1):449-50. PubMed ID: 23299663
    [No Abstract]   [Full Text] [Related]  

  • 40. Methods and interest of noninvasive assessment of liver fibrosis are still in debate.
    Degos F; Lebrun L; Perez P; Durand-Zaleski I
    Hepatology; 2011 May; 53(5):1781; author reply 1782-3. PubMed ID: 21384405
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.